STOCK TITAN

Shareholder plans 6,713-share sale in issuer (NASDAQ: LNTH)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder has filed a notice of proposed sale of 6,713 shares of common stock, with an aggregate market value of 449,570.29. The shares are to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate sale date of 02/02/2026. The issuer has 66,311,779 common shares outstanding.

The shares to be sold were acquired through restricted stock vesting and employee stock purchase plan transactions between 03/03/2022 and 09/12/2025. The filing also lists prior sales over the past three months by Paul M. Blanchfield, including multiple common stock sales with stated gross proceeds.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing for LNTH disclose?

The filing discloses a planned sale of 6,713 common shares with an aggregate market value of 449,570.29. The shares are to be sold through Fidelity Brokerage Services LLC on NASDAQ, with an approximate sale date of 02/02/2026.

How many LNTH shares are planned to be sold and on which exchange?

The notice covers a proposed sale of 6,713 common shares of the issuer. The shares are expected to be sold through Fidelity Brokerage Services LLC on the NASDAQ exchange, with an approximate sale date of 02/02/2026.

How were the LNTH shares in this Form 144 acquired?

The shares were acquired through restricted stock vesting and employee stock purchase plan (ESPP) purchases. Acquisition dates range from 03/03/2022 to 09/12/2025, with consideration described as compensation for vesting and cash for ESPP purchases.

What prior LNTH stock sales are reported for the past 3 months?

The filing lists prior common stock sales by Paul M. Blanchfield on 11/14/2025, 11/26/2025, 12/12/2025, and 01/06/2026, with respective gross proceeds of 871,106.26, 686,664.45, 218,150.98, and 501,798.01.

How many LNTH shares are outstanding according to this notice?

The document states that there are 66,311,779 common shares of the issuer outstanding. This figure provides context for the size of the proposed 6,713-share sale relative to the company’s total outstanding common stock base.

Who is the seller named in this LNTH Form 144 filing?

The seller named for recent transactions is Paul M. Blanchfield, with an address at 201 Burlington Road, South Building, Bedford, MA 01730. The filing lists his prior common stock sales and the proposed additional sale of 6,713 shares under Rule 144.
Lantheus Holding

NASDAQ:LNTH

LNTH Rankings

LNTH Latest News

LNTH Latest SEC Filings

LNTH Stock Data

4.44B
64.72M
2.24%
117.27%
11.08%
Drug Manufacturers - Specialty & Generic
In Vitro & in Vivo Diagnostic Substances
Link
United States
NORTH BILLERICA